Pharmarise Holdings Corporation

TSE:2796 Stock Report

Market Cap: JP¥6.3b

Pharmarise Holdings Past Earnings Performance

Past criteria checks 0/6

Pharmarise Holdings's earnings have been declining at an average annual rate of -27.4%, while the Consumer Retailing industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 1.1% per year.

Key information

-27.4%

Earnings growth rate

-26.7%

EPS growth rate

Consumer Retailing Industry Growth7.8%
Revenue growth rate1.1%
Return on equity-8.5%
Net Margin-1.1%
Next Earnings Update25 Dec 2024

Recent past performance updates

Recent updates

Here's Why Pharmarise Holdings (TSE:2796) Has A Meaningful Debt Burden

Aug 13
Here's Why Pharmarise Holdings (TSE:2796) Has A Meaningful Debt Burden

Pharmarise Holdings' (TSE:2796) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 22
Pharmarise Holdings' (TSE:2796) Shareholders Will Receive A Bigger Dividend Than Last Year

Pharmarise Holdings (TSE:2796) Is Paying Out A Larger Dividend Than Last Year

Mar 07
Pharmarise Holdings (TSE:2796) Is Paying Out A Larger Dividend Than Last Year

Revenue & Expenses Breakdown

How Pharmarise Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:2796 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 2456,226-6057,8270
31 May 2454,466-3514,3710
29 Feb 2453,9743024,2040
30 Nov 2353,2335343,8760
31 Aug 2352,6403453,7780
31 May 2352,0303333,7280
28 Feb 2351,7593333,5760
30 Nov 2251,4502693,5800
31 Aug 2251,4074953,5530
31 May 2251,6084473,5250
28 Feb 2252,4446343,6610
30 Nov 2152,5615493,7550
31 Aug 2152,5055443,6900
31 May 2152,3244263,6660
28 Feb 2150,896-143,6780
30 Nov 2050,9351093,5310
31 Aug 2050,998603,4600
31 May 2051,0305773,4700
29 Feb 2051,8118383,5060
30 Nov 1951,8307353,5200
31 Aug 1951,7515993,6320
31 May 1951,728233,6660
28 Feb 1952,137-3763,4810
30 Nov 1852,989-2933,4980
31 Aug 1853,856-1363,4760
31 May 1854,562-283,5470
28 Feb 1855,9324753,8070
30 Nov 1754,9452663,7700
31 Aug 1753,8721023,7220
31 May 1752,94973,5940
28 Feb 1751,398-5103,3220
30 Nov 1652,384-3173,3090
31 Aug 1650,7992653,1710
31 May 1648,5113822,9300
29 Feb 1645,3457483,0110
30 Nov 1541,5627192,6810
31 Aug 1540,4502542,5650
31 May 1539,5062272,3950
28 Feb 1539,6292303,1300
30 Nov 1439,1352732,8570
31 Aug 1438,5202182,6020
31 May 1438,2213692,3530
28 Feb 1437,7065492,5450

Quality Earnings: 2796 is currently unprofitable.

Growing Profit Margin: 2796 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 2796 is unprofitable, and losses have increased over the past 5 years at a rate of 27.4% per year.

Accelerating Growth: Unable to compare 2796's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2796 is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (10.5%).

Return on Equity

High ROE: 2796 has a negative Return on Equity (-8.49%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 09:26
End of Day Share Price 2024/12/23 00:00
Earnings2024/08/31
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharmarise Holdings Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution